Molecular Partners Ag (MOLN) EBIT Margin Growth (3y) (2023 - 2026)
Molecular Partners Ag (MOLN) EBIT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | -2,649.00 |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,786.00 |
| Dec 31, 2025 | 13.27 Mn |
| Sep 30, 2025 | -9,957.00 |
| Jun 30, 2025 | -10.13 Mn |
| Mar 31, 2025 | -11,092.00 |
| Dec 31, 2024 | 109.68 Mn |
| Sep 30, 2024 | 35,211.00 |
| Jun 30, 2024 | -103.00 Bn |
| Mar 31, 2024 | -41,399.00 |
| Dec 31, 2023 | -83,663.00 |
| Sep 30, 2023 | -45,062.00 |